AJP - Endocrinology and Metabolism, Vol 266, Issue 2 E217-E223, Copyright © 1994 by American Physiological Society

ARTICLES

Vasopressin V1 and V2 receptors in diabetes mellitus

D. Trinder, P. A. Phillips, J. M. Stephenson, J. Risvanis, A. Aminian, W. Adam, M. Cooper and C. I. Johnston
University of Melbourne, Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia.

Diabetes mellitus causes hypertonicity, increased plasma arginine vasopressin (AVP), polydipsia, and polyuria. Downregulation of AVP V2 receptors may contribute to the polyuria through diminished V2 receptor-mediated free water retention. After 2 wk of streptozotocin-induced diabetes mellitus, the diabetic rats had raised plasma glucose, AVP, and osmolality levels (P < 0.001) compared with nondiabetic controls (Sham). Insulin treatment (4 U long-acting insulin sc, daily) partially lowered these values (P < 0.01). There was a reduction in the number of renal and hepatic V1 receptors in the diabetic and diabetic+insulin animals compared with the sham animals (P < 0.05). The receptor affinity remained unchanged. In parallel, there was a reduction in maximum AVP-activated total inositol phosphate production in the liver and kidney of the diabetic and diabetic+insulin animals compared with the sham animals (P < 0.05). The density and affinity of renal V2 receptors and AVP-stimulated adenosine 3',5'-cyclic monophosphate production in the diabetic and diabetic+insulin animals were unchanged compared with the sham. These results demonstrate differential regulation of AVP receptors and suggest that downregulation of renal V2 receptors does not contribute to the polyuria of diabetes. In contrast, downregulation of V1 receptors might contribute to diminished V1 receptor-mediated biological responses to AVP seen in diabetes mellitus.

This article has been cited by other articles:

				V. Pech, J. D. Klein, S. D. Kozlowski, S. M. Wall, and J. M. Sands Vasopressin increases urea permeability in the initial IMCD from diabetic rats Am J Physiol Renal Physiol, September 1, 2005; 289(3): F531 - F535. [Abstract] [Full Text] [PDF]

				O. B. Vagnes, F. H. Hansen, J. J. Feng, B. M. Iversen, and W. J. Arendshorst Enhanced Ca2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1249 - F1256. [Abstract] [Full Text] [PDF]

				A. Agha, D. Smith, F. Finucane, M. Sherlock, A. Morris, P. Baylis, and C. J. Thompson Attenuation of vasopressin-induced antidiuresis in poorly controlled type 2 diabetes Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1100 - E1106. [Abstract] [Full Text] [PDF]

				D. Kim, J. M. Sands, and J. D. Klein Role of vasopressin in diabetes mellitus-induced changes in medullary transport proteins involved in urine concentration in Brattleboro rats Am J Physiol Renal Physiol, April 1, 2004; 286(4): F760 - F766. [Abstract] [Full Text] [PDF]

				D. Kim, J. M. Sands, and J. D. Klein Changes in renal medullary transport proteins during uncontrolled diabetes mellitus in rats Am J Physiol Renal Physiol, August 1, 2003; 285(2): F303 - F309. [Abstract] [Full Text] [PDF]

				K. McKenna, A. D. Morris, M. Ryan, R. W. Newton, B. M. Frier, P. H. Baylis, T. Saito, S. Ishikawa, and C. J. Thompson Renal resistance to vasopressin in poorly controlled type 1 diabetes mellitus Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E155 - E160. [Abstract] [Full Text] [PDF]

				P. Bardoux, H. Martin, M. Ahloulay, F. Schmitt, N. Bouby, M.-M. Trinh-Trang-Tan, and L. Bankir Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: Study in vasopressin-deficient Brattleboro rats PNAS, August 31, 1999; 96(18): 10397 - 10402. [Abstract] [Full Text] [PDF]